Tuesday October 03, 2023
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Conference & Exhibition
    • |Cell & Gene Therapy Manufacturing & Commercialization US
    • |Well Characterized Biologics & Biological Assays
    • |Cell & Gene Therapy Manufacturing & Commercialization Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Biosimilars
    • Cell/Gene Therapies
    • Continuous Bioprocessing
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Fill/Finish
    • Formulation
    • Information Technology
    • MAb
    • Manufacturing Contract Services
    • Personalized Medicine
    • Process Monitoring and Controls
    • Single Use
    • Supply Chain
    • Vaccines
    • Validation
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

June 2006 Supplement

A Fully Disposable Monoclonal Antibody Manufacturing Train

by BPI Contributor
June 1, 2006

A Stirred-Tank Bioreactor

by BPI Contributor
June 1, 2006

Deactivation of Single-Use Bioprocessing Systems Using Aqueous Chlorine Dioxide

by BPI Contributor
June 1, 2006

Disposable Membrane Chromatography

by BPI Contributor
June 1, 2006

Disposable Technologies for Aseptic Filling

by BPI Contributor
June 1, 2006

Not Just Throwaway Technology

by BPI Contributor
June 1, 2006

Preparation of Redundant, Disposable Filtration Systems

by BPI Contributor
June 1, 2006

Quantification of Protein Adsorption onto the Surface of Single-Use Flexible Containers

by BPI Contributor
June 1, 2006

Suitability of Selected Single-Use Process Monitoring and Control Technology

by BPI Contributor
June 1, 2006

The BioProcess Systems Alliance

by BPI Contributor
June 1, 2006
  • 1
  • 2
  • >

  • BioProcess Insider

    It is a perilous time to establish a CDMO operation, says expert

  • BioProcess Insider

    Out of Africa? No! Very much in it, says BioNTech

  • Sponsored Content

    Scalable mRNA Affinity Capture: Supporting Development and Production of mRNA-Based Therapeutics

  • BioProcess Insider

    It’s not me, it’s you! Experts on when you should dump your CDMO

  • BioProcess Insider

    IRA and political rhetoric harming pharma reputation and innovation, Amicus

  • Sponsored Content

    Leveraging dPCR Techniques to Quantitate Lentivirus Particles


BioProcess International BIO Theater

Recent Tweets

  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Development of IEX Purification Process for Lentiviral Vectors." Date: T… https://t.co/vgK15PE2rB 5 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/7jyYh7UsoM 5 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/zokTnEdk6F 5 months ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/lR7nAmnryf 5 months ago
Follow @bioprocessintl

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2023 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International Conference & Exhibition
    • Cell & Gene Therapy Manufacturing & Commercialization US
    • Well Characterized Biologics & Biological Assays
    • Cell & Gene Therapy Manufacturing & Commercialization Europe
  • BioProcess International Academy
  • Events